Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. - Wikidata - awgldk - TriplyDB

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

http://www.wikidata.org/entity/Q33593176

about

Myalgic encephalomyelitis: International Consensus Criteria A Role for the Intestinal Microbiota and Virome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)?Understanding Muscle Dysfunction in Chronic Fatigue Syndrome Myalgic Encephalomyelitis: Symptoms and Biomarkers Myalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristics Illness progression in chronic fatigue syndrome: a shifting immune baseline Tracking post-infectious fatigue in clinic using routine Lab tests The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem A comparison of health status in patients meeting alternative definitions for chronic fatigue syndrome/myalgic encephalomyelitis.Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and sickness behavior.Immunophenotyping in post-giardiasis functional gastrointestinal disease and chronic fatigue syndrome Lack of evidence for retroviral infections formerly related to chronic fatigue in Spanish fibromyalgia patients.Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome.Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study.Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis.Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis.Gene expression alterations at baseline and following moderate exercise in patients with Chronic Fatigue Syndrome and Fibromyalgia Syndrome.Natural killer cells in patients with severe chronic fatigue syndrome.A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome.MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)Chronic fatigue syndrome and subsequent risk of cancer among elderly US adults.Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis.Screening NK-, B- and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome Novel identification and characterisation of Transient receptor potential melastatin 3 ion channels on Natural Killer cells and B lymphocytes: effects on cell signalling in Chronic fatigue syndrome/Myalgic encephalomyelitis patients.Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.Deficient EBV-specific B- and T-cell response in patients with chronic fatigue syndrome.Biomarkers for chronic fatigue.A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.Association of musculoskeletal complaints and gliptin use: review of spontaneous reports.Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.Unperturbed Cytotoxic Lymphocyte Phenotype and Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles.Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation.Association of T and NK Cell Phenotype With the Diagnosis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

P2860

Q24611510-075741FD-943C-467E-87DD-26C0E9ECEDAE Q26747503-A96120E2-6523-4908-9853-9CEEA1BE2FDB Q26753111-DCD93ACF-0233-452C-90B0-4C8B553015C1 Q26786545-8DCE3248-46CC-4453-AE6C-93ECA4B9CBAE Q26998412-95844A7B-0FF1-44BF-A62A-C7092FCF083F Q28389279-D8E5F4DD-CF8E-4324-BA36-558B24B44F6D Q28393209-946A5B1C-C994-4B78-BDC5-4FF788552935 Q28394255-106123B5-9C69-4963-9C68-BD365A26A9C7 Q33560154-A8F5AA5E-D56B-4E89-9066-28FDCE17A4CB Q33737919-4D3386C4-82A7-4122-B4B3-99FAB2AFFD34 Q34333249-C346833F-B947-4396-8BAC-70B180FA67AB Q34444343-038C6634-EA06-4BEE-AF2D-A7DAF6ECBE56 Q34480257-483481C6-948E-4E1B-BDC1-214FD118EF3C Q34506820-CDC15C82-3F81-4B35-B07C-0501047515C7 Q34553410-13520A8F-2B2C-4F7C-AC89-676F50D3C056 Q35060449-A01BCFD1-6219-488F-9B19-90A43D473338 Q35061216-EA315EF6-CF7F-4689-A474-52D188F6247C Q35219064-79C3BEBC-1DE3-4263-8358-51965B7AEE08 Q35309120-11434414-7D51-4522-9C26-FE5090531E96 Q35875673-95AE0CC7-8102-4EE3-86CA-293BB6BF8A82 Q35954084-4612D6CF-8C4C-4885-BD0D-C90EC14DA443 Q36210164-721F6AD6-2EFB-4300-942C-E660599FCA7D Q36298951-6A4C28FE-4B44-46C5-AA57-21652657862F Q36735025-BD84FE94-AEC8-4CF3-B9DC-0EFC5016F68F Q36955692-C92A1627-CB0C-4FB5-A550-F7D4F1E9DE7C Q37221100-29158398-E201-4E73-9D6E-E2DCB9202FBF Q37410661-52C15409-A0AB-49AC-B550-E1CB3F2030AE Q37484088-8AE10830-49CE-4815-ABBC-C82C87C8D910 Q37730322-58AE08F5-7170-4929-8C8F-9ADDB0416388 Q38020430-EC790FAF-FE99-47B2-9177-79002AAF72CC Q38130192-A8C38DEC-8107-471C-9DA2-64619C682E1F Q38650323-AE65FD61-62E4-4C0A-8E6C-E837EF0E26E7 Q40128256-AE18A613-6084-40B2-B424-0B7B51A83E35 Q40511188-502D5773-F2D9-4949-B945-DDEE2E9A6874 Q42248672-29ED0F2F-BE92-4CB9-9542-7C485C31D2A9 Q50689763-50DBB348-509F-4C8A-AA22-0A83F83E7B8B Q51733779-41C11EF3-090B-4325-92AA-15BD60D91533 Q55387468-0E5726DB-4D62-472B-BCFC-BBFD9774BC5B

P2860

Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26.

http://www.wikidata.org/entity/Q33593176

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Biomarkers in chronic fatigue ...... dipeptidyl peptidase IV/CD26.

@ast

Biomarkers in chronic fatigue ...... dipeptidyl peptidase IV/CD26.

@en

type

label

Biomarkers in chronic fatigue ...... dipeptidyl peptidase IV/CD26.

@ast

Biomarkers in chronic fatigue ...... dipeptidyl peptidase IV/CD26.

@en

prefLabel

Biomarkers in chronic fatigue ...... dipeptidyl peptidase IV/CD26.

@ast

Biomarkers in chronic fatigue ...... dipeptidyl peptidase IV/CD26.

@en

P1433

Q33593176-3483FA0F-976E-4D96-B994-932F71676EE5

P1476

Q33593176-7C9EC71F-71FC-489F-A2BB-23FA7177C42C

P2093

Q33593176-234C1F39-AA37-456F-ABF0-84784815BB4B

Q33593176-48A8FB6C-E605-4635-A48F-8FB51B027CF8

Q33593176-87029E9E-DC24-409C-B363-5C4CA9BA5241

Q33593176-88162C14-F07A-4986-9196-190CD83D1927

Q33593176-8D8B8B4D-9296-4486-A6EA-5ADC8396434A

Q33593176-A17F6778-4D12-4BDA-9E20-538B1D7F2570

P2860

Q33593176-02FF10C0-9BEF-4937-BB17-DE9B203D92A2

Q33593176-0495180C-316A-46B1-9E1B-BC1462925B8C

Q33593176-09796F56-C9C7-47A5-8AC0-750FA4BFD76F

Q33593176-0BF04A19-9259-4051-958C-C8E699D7E8EF

Q33593176-11D83E89-C128-48CF-86F4-7DBB106C542C

Q33593176-1CD5D954-CF4D-4A0F-BB93-B6EFA244D3A9

Q33593176-1E8567CD-D9AD-4E83-A6EA-D69353C746ED

Q33593176-287A541E-4E31-4E1F-9730-F44472002C11

Q33593176-2B316ACA-5B0A-49E2-BAD5-D9DC18EF1801

Q33593176-3BE2E703-EA52-485E-AFD0-05242F370683

P304

Q33593176-00D906FA-F34A-447B-9A50-9FA4149D235C

P31

Q33593176-76D6A0B6-E636-441A-99F4-01524AD41FFB

P356

Q33593176-3C2719BC-DE80-44B6-858D-C351EDB8713B

P407

Q33593176-477E4DB2-A57E-43B2-ABAE-FF90C485DC78

P433

Q33593176-68F2B5CC-494F-490C-B94A-1AEB62C35E3B

P478

Q33593176-75BD6E29-D59D-4471-A4ED-5F7B8EB76453

P50

Q33593176-8613F022-2742-41A8-B0BA-AA7755BF84BB

Q33593176-ADC28BD8-4519-441F-A83E-D57F1E08AE57

P577

Q33593176-4D7F6854-E2F1-419E-B7A2-01AD763835D0

P5875

Q33593176-688DA5F7-E31B-4476-BB1B-08DF7459B6FC

P698

Q33593176-9B883A43-AAD6-4EFA-934C-A1A10AEE9667

P921

Q33593176-DEF28850-E8E4-4A31-A974-844B2EDB7C66

P932

Q33593176-F76511E9-F147-457B-BD9D-AC261D656E24

P356

JOURNAL.PONE.0010817

P1433

P1476

Biomarkers in chronic fatigue ...... dipeptidyl peptidase IV/CD26.

@en

P2093

Barry Hurwitz

http://www.w3.org/2001/XMLSchema#string

Kevin Maher

http://www.w3.org/2001/XMLSchema#string

Mary A Fletcher

http://www.w3.org/2001/XMLSchema#string

Michael Antoni

http://www.w3.org/2001/XMLSchema#string

Silvina Levis

http://www.w3.org/2001/XMLSchema#string

Xiao R Zeng

http://www.w3.org/2001/XMLSchema#string

P2860

Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome

The economic impact of ME/CFS: individual and societal costs

Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution

The economic impact of chronic fatigue syndrome

Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome

Immunologic abnormalities in chronic fatigue syndrome

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

Chronic fatigue syndrome: clinical condition associated with immune activation

Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome

Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes

P304

e10817

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0010817

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Nancy G. Klimas

Gordon Broderick

P577

2010-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44646960

http://www.w3.org/2001/XMLSchema#string

P698

20520837

http://www.w3.org/2001/XMLSchema#string

P921

P932

2876037

http://www.w3.org/2001/XMLSchema#string